Skip to Main Content

Paper Details

Atezolizumab for PD-L1-Selected Patients with NSCLC.
N Engl J Med
3
2021
Author NameAffiliation
Roy S HerbstYokohama City University Graduate School of Medicine
  • 1 - 1

Datasets

Release 1.2